EMEA-000128-PIP01-07-M08
Key facts
Invented name |
Victoza
|
Active substance |
liraglutide
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0218/2017
|
PIP number |
EMEA-000128-PIP01-07-M08
|
Pharmaceutical form(s) |
Solution for injection (in prefilled pen)
|
Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Novo Nordisk A/S
Denmark |
Decision type |
PM: decision on the application for modification of an agreed PIP
|